Mckesson Corp
NYSE:MCK
Intrinsic Value
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. [ Read More ]
The intrinsic value of one MCK stock under the Base Case scenario is 846.17 USD. Compared to the current market price of 524.83 USD, Mckesson Corp is Undervalued by 38%.
Valuation Backtest
Mckesson Corp
Run backtest to discover the historical profit from buying and selling MCK stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Mckesson Corp
Current Assets | 47.6B |
Cash & Short-Term Investments | 2B |
Receivables | 23.1B |
Other Current Assets | 22.6B |
Non-Current Assets | 18.9B |
Long-Term Investments | 213m |
PP&E | 3.9B |
Intangibles | 12.1B |
Other Non-Current Assets | 2.7B |
Current Liabilities | 51.7B |
Accounts Payable | 46.7B |
Accrued Liabilities | 4.7B |
Short-Term Debt | 218m |
Other Current Liabilities | 48m |
Non-Current Liabilities | 16.9B |
Long-Term Debt | 5.6B |
Other Non-Current Liabilities | 11.3B |
Earnings Waterfall
Mckesson Corp
Revenue
|
301.5B
USD
|
Cost of Revenue
|
-289.2B
USD
|
Gross Profit
|
12.3B
USD
|
Operating Expenses
|
-8.4B
USD
|
Operating Income
|
3.9B
USD
|
Other Expenses
|
-921m
USD
|
Net Income
|
3B
USD
|
Free Cash Flow Analysis
Mckesson Corp
What is Free Cash Flow?
MCK Profitability Score
Profitability Due Diligence
Mckesson Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Mckesson Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
MCK Solvency Score
Solvency Due Diligence
Mckesson Corp's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Mckesson Corp's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MCK Price Targets Summary
Mckesson Corp
According to Wall Street analysts, the average 1-year price target for MCK is 575.85 USD with a low forecast of 507.02 USD and a high forecast of 651 USD.
Ownership
MCK Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
MCK Price
Mckesson Corp
Average Annual Return | 36.71% |
Standard Deviation of Annual Returns | 13.13% |
Max Drawdown | -4% |
Market Capitalization | 68.8B USD |
Shares Outstanding | 131 410 000 |
Percentage of Shares Shorted | 1.11% |
MCK News
Last Important Events
Mckesson Corp
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Mckesson Corp
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. The company is headquartered in Irving, Texas and currently employs 59,000 full-time employees. The firm is focused on providing health information technology, and care management tools. The Company’s segments include U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. The International segment provides services to wholesale, institutional, in 13 European countries and Canada. Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. RxTS segment combines its technologies, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, to serve its biopharma and life sciences partners and patients.
Contact
IPO
Employees
Officers
The intrinsic value of one MCK stock under the Base Case scenario is 846.17 USD.
Compared to the current market price of 524.83 USD, Mckesson Corp is Undervalued by 38%.